CDKN2A and neoplasm: These results provide further evidence that, in HUVECs, the ARF tumor suppressor promoter is activated by distinct E2F1 activity but not by physiological E2F1 activity, induced by growth stimulation, suggesting that the regulation of tumor suppressor genes by E2F1 is distinct from that of cell cycle-related genes in endothelial cells.